References
- Falini B. Anaplastic large cell lymphoma: pathologic, molecular and clinical features. Br J Haematol 2001; 114: 741–760
- Morris S W, Kirstein M N, Valentine M B, Valentine M B, Dittmer K G, Shapiro D N, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281–1284
- Gascoyne R D, Aoun P, Wu D, Chhanabhai M, Skinnider B F, Greiner T C, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999; 93: 3913–3921
- Bekkenk M, Geelen F, van Voorst Vader P, Heule F, Geerts M L, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000; 95: 3653–3661
- Winhoven S, Murugesan S, Coulson I. Solitary CD30+ anaplastic large cell lymphoma of the eyelid showing regression. Br J Ophthamol 2005; 89: 385
- Savarrio L, Gibson J, Dunlop D, O'Rourke N, Fitzsimons F. Spontaneous regression of an anaplastic large cell lymphoma in the oral cavity: first reported case and review of the literature. Oral Oncol 1999; 35: 609–613
- DeCoteau J, Butmarc J, Kinney M, Kadin M. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996; 87: 3437–3441
- Wood G, Hardman D, Boni R, Dummer R, Kim Y H, Smoller B R, et al. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood 1996; 88: 1765–1770
- Kamiya T, Saga K, Yanagisawa K, Kaneko R, Yamashita T, Ishida O, et al. Small cell variant of CD30+ primary cutaneous T-cell lymphoma with epidermotropism that completely regressed after incisional skin biopsy. Br J Dermatol 2006; 155: 484–487
- Falini B, Pulford K, Pucciarini A, Carbone A, De Wolf-Peeters C, Cordell J, et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 1999; 94: 3509–3515
- Hernández L, Pinyol M, Hernández S, Bea S, Pulford K, Rosenwald A, et al. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood 1999; 94: 3265–3268
- Lamant L, Dastugue N, Pulford K, Delsol G, Mariamé B. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood 1999; 93: 3088–3095
- Mason D, Bastard C, Rimokh R, Dastugue N, Huret J L, Kristoffersson U, et al. CD30-positive large cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35. Br J Haematol 1990; 74: 161–168
- Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M, et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 1995; 86: 1954–1960